Sm29, but Not Sm22.6 Retains its Ability to Induce a Protective Immune Response in Mice Previously Exposed to a Schistosoma mansoni Infection
The development of a vaccine against schistosomiasis together with chemotherapy would have a great impact in the disease control and elimination. Sm29 and Sm22.6 are two promising antigens that have been associated with resistance to infection/reinfection in humans and also successfully induce prote...
Main Authors: | , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344193/ |